CMC/Manufacturing

BriSTAR has developed a flexible cell process development and manufacturing platform from preclinical process development to clinical material manufacturing that supports the development of a new generation of personalized cell therapy products (STAR-T and enTCR-T products).

The company’s enhanced platform expedites timelines and drives our speed-to-market efforts.